American International Group, Inc. Infinity Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.49 - $1.2 $21,294 - $52,150	-43,459 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.85 - $2.4 $2,600 - $7,341	-3,059 Reduced 6.58%	43,459 $50,000
Q4 2021 Feb 11, 2022	SELL	$1.86 - $3.36 $2,589 - $4,677	-1,392 Reduced 2.91%	46,518 $105,000
Q3 2021 Nov 12, 2021	SELL	$1.52 - $3.82 $1,729 - $4,347	-1,138 Reduced 2.32%	47,910 $164,000
Q2 2021 Aug 13, 2021	BUY	$2.66 - $3.47 $130,467 - $170,196	49,048 New	49,048 $147,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.